News Oligomerix to Present at BIO CEO & Investor Conference, Tau2020 Global Conference February 6, 2020 By vera This article is sourced from an external publication. Read the original → ← PreviousStudy Might Point Alzheimer’s Research in Whole New Direction U.S. NewsNext →Oligomerix Presents Preclinical Data at TAU2020 Global Conference for Small Molecule Inhibitor of Tau Self-Association
